Parliament rejected the EU Withdrawal Agreement negotiated by Theresa May's government for a third time on Friday afternoon....more
4/2/2019
/ Consumer Protection Act ,
EU ,
Imports ,
Manufacturers ,
Member State ,
No-Deal Brexit ,
Product Labels ,
Supply Chain ,
Theresa May ,
Transitional Arrangements ,
UK ,
UK Brexit ,
Withdrawal Agreement
Given developments last week, Brexit remains top of the agenda. While the UK government doesn't have the same level of "shut down" as the US government, clearly very considerable resources are currently being diverted to...more
The UK government has recently published a further series of technical notices to guide businesses and citizens as to what they would need to do if the UK leaves the EU without a withdrawal agreement in place – the 'no deal'...more
Innovation in the life sciences and health care industries is occurring at a dizzying pace. Five years ago, anti-PD-1 antibodies from Merck and BMS had yet to be approved, CAR-T therapies were still in small-scale clinical...more
4/4/2018
/ 3D Printing ,
Acquisitions ,
Artificial Intelligence ,
Biologics ,
Biosimilars ,
Biotechnology ,
Blockchain ,
Cyber Attacks ,
Cybersecurity ,
Data Breach ,
Digital Health ,
Distributed Ledger Technology (DLT) ,
Drug Pricing ,
Emerging Markets ,
EU ,
General Data Protection Regulation (GDPR) ,
Generic Drugs ,
Innovation ,
Life Sciences ,
Medical Reimbursement ,
Mergers ,
Over The Counter Derivatives (OTC) ,
Pharmaceutical Industry ,
Prescription Drugs ,
Private Equity ,
Regulatory Oversight ,
Supply Chain ,
Transfer Pricing ,
UK Brexit ,
Yates Memorandum